Sanofi has said it plans to start discussions about filing its oral BTK inhibitor tolebrutinib for multiple sclerosis, even though the drug only achieved its primary objective in one of three phase 3 ...
President Donald Trump’s approval rating ticked up four points from April in the latest Washington Post-Ipsos survey that found 43% approve of his job performance—on par with his 41% average rating ...
President Donald Trump’s approval rating improved in two polls and fell in another this week—as Americans’ feelings about his use of the National Guard to tamp down on crime in large U.S. cities are ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback